Skip to content

Effect of oral pregabalin on post operative pain after laparoscopic Gastric Bypass surgery

Evaluation the effect of oral pregabalin on post operative pain after laparoscopic Gastric Bypass surgery

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201102255184N2
Enrollment
60
Registered
2012-01-28
Start date
2009-08-30
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain control. Postoperative acute pain control

Interventions

Intervention 1: In the study group, 300 milligrams pregabalin, one hour before surgery. Intervention 2: In the control group, 300 milligrams placebo, one hour before surgery.
Treatment - Drugs
Placebo
In the study group, 300 milligrams pregabalin, one hour before surgery
In the control group, 300 milligrams placebo, one hour before surgery

Sponsors

Vice chancellor for research, Tehran University of Medical Sciences and Health Services
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age 18-50 yr; ASA Class I- II Exclusion criteria: Systolic Blood pressure less than 90 mmHg; Substance abuse; Pregnancy and breast feeding; Nonsteroidal anti-inflammatory drugs sensitivity; Asthma and Allergic rhinitis, Peptic ulcer disease

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain score. Timepoint: At recovery, 30 minutes, 2,4,12 and 24 hours after surgery. Method of measurement: VAS.

Secondary

MeasureTime frame
Opioid consumption. Timepoint: 24 hours after surgery. Method of measurement: By PCA.;Nausea & vomiting. Timepoint: 24 hours after surgery. Method of measurement: By asking the patient the question.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahzad Alimian

Rasul Hospital

m-alimian@tums.ac.ir+98 21 6650 9059

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026